Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 3 | 2023 | 22 | 2.200 |
Why?
|
| Neuroma, Acoustic | 6 | 2022 | 10 | 2.160 |
Why?
|
| Cochlear Implants | 3 | 2023 | 30 | 2.160 |
Why?
|
| Tinnitus | 6 | 2019 | 12 | 2.050 |
Why?
|
| Vestibule, Labyrinth | 3 | 2022 | 6 | 1.820 |
Why?
|
| Otosclerosis | 8 | 2021 | 8 | 1.530 |
Why?
|
| Ear, Middle | 4 | 2019 | 8 | 1.500 |
Why?
|
| Stapes Surgery | 8 | 2021 | 8 | 1.390 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 16 | 1.110 |
Why?
|
| Postoperative Complications | 9 | 2021 | 957 | 1.050 |
Why?
|
| Ear Neoplasms | 2 | 2015 | 6 | 0.980 |
Why?
|
| Internship and Residency | 2 | 2018 | 213 | 0.980 |
Why?
|
| Hydroxyapatites | 3 | 2020 | 9 | 0.930 |
Why?
|
| Neurilemmoma | 2 | 2022 | 16 | 0.930 |
Why?
|
| Otolaryngology | 3 | 2020 | 27 | 0.900 |
Why?
|
| Otologic Surgical Procedures | 4 | 2017 | 4 | 0.860 |
Why?
|
| Speech Perception | 1 | 2023 | 48 | 0.860 |
Why?
|
| Humans | 48 | 2023 | 29814 | 0.850 |
Why?
|
| Retrospective Studies | 23 | 2023 | 3325 | 0.780 |
Why?
|
| Craniotomy | 2 | 2019 | 24 | 0.740 |
Why?
|
| Bone Cements | 2 | 2020 | 90 | 0.730 |
Why?
|
| Endoscopy | 2 | 2018 | 181 | 0.710 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2019 | 1 | 0.680 |
Why?
|
| Dizziness | 1 | 2019 | 20 | 0.670 |
Why?
|
| Temporal Bone | 2 | 2017 | 10 | 0.660 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 18 | 0.630 |
Why?
|
| Ear, Inner | 3 | 2019 | 4 | 0.610 |
Why?
|
| Malleus | 1 | 2017 | 1 | 0.610 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3561 | 0.590 |
Why?
|
| Skull | 1 | 2017 | 25 | 0.580 |
Why?
|
| Stapedius | 1 | 2017 | 1 | 0.570 |
Why?
|
| Vascular Malformations | 1 | 2017 | 4 | 0.570 |
Why?
|
| Incidental Findings | 1 | 2017 | 16 | 0.570 |
Why?
|
| Ear Canal | 2 | 2022 | 4 | 0.560 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 221 | 0.560 |
Why?
|
| Cartilage | 1 | 2017 | 154 | 0.550 |
Why?
|
| Male | 26 | 2021 | 15851 | 0.540 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 132 | 0.530 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 4 | 0.520 |
Why?
|
| Middle Aged | 22 | 2021 | 9960 | 0.520 |
Why?
|
| Stroke | 1 | 2019 | 294 | 0.520 |
Why?
|
| Microsurgery | 2 | 2015 | 40 | 0.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 60 | 0.510 |
Why?
|
| Exostoses | 1 | 2015 | 1 | 0.510 |
Why?
|
| Osteoma | 1 | 2015 | 5 | 0.510 |
Why?
|
| Microscopy | 1 | 2015 | 11 | 0.500 |
Why?
|
| Lighting | 1 | 2015 | 16 | 0.500 |
Why?
|
| Adult | 21 | 2021 | 8741 | 0.490 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 778 | 0.480 |
Why?
|
| Meniere Disease | 3 | 2021 | 3 | 0.480 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2014 | 1 | 0.480 |
Why?
|
| Eyeglasses | 1 | 2014 | 3 | 0.480 |
Why?
|
| Eye Movements | 1 | 2014 | 21 | 0.480 |
Why?
|
| Physician's Role | 1 | 2014 | 17 | 0.460 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 106 | 0.460 |
Why?
|
| Adenoma | 1 | 2014 | 41 | 0.460 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2012 | 1 | 0.430 |
Why?
|
| Eustachian Tube | 2 | 2019 | 4 | 0.430 |
Why?
|
| Biomarkers | 1 | 2016 | 704 | 0.420 |
Why?
|
| Female | 25 | 2021 | 16412 | 0.420 |
Why?
|
| Acoustic Impedance Tests | 1 | 2011 | 1 | 0.390 |
Why?
|
| Hearing Loss | 2 | 2021 | 11 | 0.380 |
Why?
|
| Reoperation | 6 | 2021 | 927 | 0.380 |
Why?
|
| Hearing Loss, Sudden | 1 | 2010 | 1 | 0.370 |
Why?
|
| Heroin | 1 | 2010 | 3 | 0.370 |
Why?
|
| Aged | 17 | 2020 | 9620 | 0.370 |
Why?
|
| Hearing Aids | 1 | 2010 | 3 | 0.370 |
Why?
|
| Triage | 1 | 2010 | 23 | 0.360 |
Why?
|
| Family Practice | 1 | 2010 | 20 | 0.360 |
Why?
|
| Cerebellopontine Angle | 2 | 2020 | 5 | 0.350 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 398 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 334 | 0.300 |
Why?
|
| Stapes | 3 | 2021 | 3 | 0.290 |
Why?
|
| Hearing | 3 | 2021 | 22 | 0.280 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 4930 | 0.280 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 77 | 0.270 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 2 | 0.260 |
Why?
|
| Encephalocele | 2 | 2022 | 26 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 1247 | 0.250 |
Why?
|
| Adolescent | 7 | 2021 | 2332 | 0.250 |
Why?
|
| Tympanic Membrane | 2 | 2017 | 4 | 0.250 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 6 | 0.250 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2021 | 3 | 0.240 |
Why?
|
| Endolymphatic Sac | 1 | 2004 | 2 | 0.240 |
Why?
|
| Databases as Topic | 1 | 2023 | 19 | 0.230 |
Why?
|
| Facial Nerve | 3 | 2020 | 13 | 0.210 |
Why?
|
| Radiosurgery | 2 | 2020 | 34 | 0.210 |
Why?
|
| Cranial Fossa, Middle | 1 | 2022 | 6 | 0.210 |
Why?
|
| Cochlea | 1 | 2022 | 2 | 0.210 |
Why?
|
| Mastoidectomy | 1 | 2022 | 1 | 0.210 |
Why?
|
| Ossicular Prosthesis | 2 | 2020 | 2 | 0.200 |
Why?
|
| Mastoid | 3 | 2022 | 3 | 0.200 |
Why?
|
| Ossicular Replacement | 1 | 2020 | 1 | 0.190 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 8 | 0.190 |
Why?
|
| Facial Paralysis | 1 | 2020 | 7 | 0.190 |
Why?
|
| Anesthesia, General | 1 | 2020 | 30 | 0.180 |
Why?
|
| Arteries | 1 | 2020 | 17 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 7 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2014 | 141 | 0.180 |
Why?
|
| Urban Health Services | 1 | 2020 | 13 | 0.180 |
Why?
|
| Young Adult | 5 | 2020 | 1966 | 0.170 |
Why?
|
| Ear Diseases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 152 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 401 | 0.170 |
Why?
|
| Tuberculosis | 1 | 2019 | 25 | 0.170 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 7 | 0.170 |
Why?
|
| Quality of Life | 1 | 2004 | 677 | 0.170 |
Why?
|
| Disease Management | 1 | 2020 | 122 | 0.160 |
Why?
|
| Skull Base | 1 | 2019 | 26 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 75 | 0.160 |
Why?
|
| Telemedicine | 1 | 2020 | 99 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 89 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 129 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 81 | 0.150 |
Why?
|
| Sepsis | 1 | 2019 | 147 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 234 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2020 | 425 | 0.150 |
Why?
|
| Child | 4 | 2021 | 1377 | 0.140 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2021 | 10 | 0.140 |
Why?
|
| Risk Factors | 4 | 2021 | 2465 | 0.140 |
Why?
|
| Cadaver | 1 | 2017 | 362 | 0.140 |
Why?
|
| Chemokines | 1 | 2016 | 29 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 200 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 558 | 0.130 |
Why?
|
| Vestibular Function Tests | 1 | 2015 | 2 | 0.130 |
Why?
|
| Hearing Disorders | 1 | 2015 | 2 | 0.130 |
Why?
|
| Semicircular Canals | 1 | 2015 | 5 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 78 | 0.130 |
Why?
|
| Endometrium | 1 | 2015 | 6 | 0.130 |
Why?
|
| Hemifacial Spasm | 1 | 2014 | 2 | 0.120 |
Why?
|
| Burns | 1 | 2015 | 21 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2015 | 36 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 27 | 0.120 |
Why?
|
| Melanoma | 1 | 2015 | 52 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 67 | 0.120 |
Why?
|
| United States | 2 | 2018 | 2344 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 110 | 0.120 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Vestibular Nerve | 1 | 2013 | 3 | 0.120 |
Why?
|
| Rotation | 1 | 2014 | 142 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 194 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1126 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2014 | 25 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 58 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 508 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2014 | 85 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 144 | 0.110 |
Why?
|
| Gentamicins | 2 | 2002 | 16 | 0.110 |
Why?
|
| Anxiety | 1 | 2014 | 157 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 2 | 2021 | 3 | 0.100 |
Why?
|
| Comorbidity | 1 | 2014 | 504 | 0.100 |
Why?
|
| HIV Infections | 1 | 2019 | 997 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 379 | 0.100 |
Why?
|
| Bone Conduction | 2 | 2021 | 2 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 8 | 0.100 |
Why?
|
| Auditory Threshold | 1 | 2010 | 15 | 0.090 |
Why?
|
| Drug Overdose | 1 | 2010 | 8 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2011 | 113 | 0.090 |
Why?
|
| Meditation | 1 | 2010 | 11 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2010 | 36 | 0.090 |
Why?
|
| Respiration | 1 | 2010 | 35 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 51 | 0.090 |
Why?
|
| Tympanoplasty | 2 | 2017 | 3 | 0.090 |
Why?
|
| Depression | 1 | 2014 | 472 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 636 | 0.090 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 106 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 249 | 0.080 |
Why?
|
| Time Factors | 2 | 2020 | 1641 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1952 | 0.060 |
Why?
|
| Round Window, Ear | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 403 | 0.050 |
Why?
|
| Labyrinthine Fluids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Otitis Media | 1 | 2002 | 5 | 0.050 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 802 | 0.050 |
Why?
|
| Contraindications | 1 | 2021 | 42 | 0.050 |
Why?
|
| Granuloma | 1 | 2021 | 13 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2020 | 2 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1726 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 21 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 39 | 0.040 |
Why?
|
| South Africa | 1 | 2019 | 17 | 0.040 |
Why?
|
| Neuroma | 1 | 2019 | 4 | 0.040 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 4 | 0.040 |
Why?
|
| Myoclonus | 1 | 2019 | 34 | 0.040 |
Why?
|
| Meningioma | 1 | 2019 | 18 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 14 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 1187 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 66 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 67 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 237 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 63 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 532 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 331 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 158 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 124 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 3 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 26 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 34 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 43 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 53 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 65 | 0.030 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 20 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 35 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 79 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 108 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 149 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 299 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 388 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 58 | 0.010 |
Why?
|
| Fascia | 1 | 2002 | 9 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 654 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1823 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 1859 | 0.010 |
Why?
|